Esperion Therapeutics, Inc. (LON:0IIM)

Esperion Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	169	346	267	381	226	531
Market Cap Growth	-43.84%	29.71%	-29.94%	68.53%	-57.42%	-56.85%
Enterprise Value	522	678	594	676	536	503
Last Close Price	0.92	1.74	2.39	4.92	3.73	20.88
PS Ratio	0.84	1.30	2.92	6.08	3.90	3.19
PB Ratio	-0.51	-1.11	-0.75	-1.42	-1.55	-7.54
EV/Sales Ratio	2.73	2.55	6.51	10.79	9.26	3.02
EV/EBITDA Ratio	-	15.58	-	-	-	-
EV/EBIT Ratio	-	15.59	-	-	-	-
Debt / Equity Ratio	-1.39	-1.52	-1.19	-1.56	-2.63	-3.77
Debt / EBITDA Ratio	-	10.29	-	-	-	-
Asset Turnover	0.75	1.21	0.51	0.24	0.21	0.80
Inventory Turnover	1.57	1.43	2.57	4.19	4.76	-
Quick Ratio	0.72	0.91	0.84	2.17	3.85	3.37
Current Ratio	1.18	1.37	1.29	2.67	4.49	3.68
Return on Assets (ROA)	-7.17%	12.37%	-42.86%	-35.64%	-36.31%	-26.73%
Return on Capital (ROIC)	-11.83%	23.58%	-72.90%	-44.78%	-45.52%	-36.13%
Return on Capital Employed (ROCE)	-	55.70%	-	-	-	-
Earnings Yield	-70.12%	-11.94%	-61.54%	-50.90%	-87.91%	-19.81%
FCF Yield	-45.93%	-5.53%	-39.85%	-38.09%	-86.18%	-11.87%
Buyback Yield / Dilution	-54.12%	-81.54%	-55.26%	-129.76%	-5.20%	-1.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.